What’s New in Reversed-Phase Liquid Chromatography Selectivity? An Update from the Perspective of the Hydrophobic Subtraction Model ...

What’s New in Reversed-Phase Liquid Chromatography Selectivity? An Update from the Perspective of the Hydrophobic Subtraction Model ...

A recent joint study between the University of Ferra and YMC ChromaCon led an effort to a new approach to more efficiently purify oligonucleotides. Scientists from the University of Ferrara in Ferrara ...

Welcome to “Analytically Speaking,” the podcast from LCGC International and Spectroscopy. In this episode, podcast co-hosts Dr. Dwight Stoll and Dr. James Grinias talk with Dr. Benjamin Garcia. Dr.

Scientists from the University of Oslo in Norway have combined electromembrane extraction (EME) and flow injection-tandem mass spectrometry (FI–MS/MS) to determine polar endogeneous metabolites in ...

Shimadzu Corporation is celebrating 150 years since it was founded with a dedicated website and a collaboratively designed logo. Shimadzu Corporation is celebrating a significant milestone in 2025: ...

Polysorbates (PS) are added to biopharmaceutical formulations to stabilize proteins and monoclonal antibodies (mAbs) and to prevent aggregation, denaturation, and surface adsorption. Polysorbate ...

The use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented. Recombinant human acid ...

As analytical science continues to evolve within both academic and industrial landscapes, the editors of LCGC International are equally focused on reimagining how we can deliver more innovative and ...

Throughout 2024, the editors of LCGC International attended chromatography conferences across the globe. From Munich, Germany, to San Diego, California, they were on-site at some of the world’s ...

Gas chromatography (GC) is a cornerstone of analytical chemistry, known for its versatility. At LCGC International, we have actively covered developments in GC through our technical articles, news ...

mRNA-based vaccines and therapeutics requires the verification of terminal structures including 5’-terminal capping, proportion of capped mRNA species, and 3’-terminal poly A tail analysis. Another ...